Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Pharmaceutics|February 21, 2020
Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide NanoparticlesNoriaki Nagai, Miyu Ishii, Ryotaro Seiriki, et al.
Current Eye Research|November 11, 2009
Pyroglutamic acid promotes survival of retinal ganglion cells after optic nerve injuryShinichirou Oono, Takuji Kurimoto, Toru Nakazawa, et al.
JAMA Ophthalmology|October 16, 2014
Landolt ring-shaped epithelial keratopathy: a novel clinical entity of the corneaTomoyuki Inoue, Naoyuki Maeda, Xiaodong Zheng, et al.
Anticancer Research|July 5, 2020
The Association Between Extracellular Water-to-Total Body Water Ratio and Therapeutic Durability for Advanced Lung CancerYoshimi Noda, Hidekazu Suzuki, Tomohiro Kanai, et al.
Oncology Letters|June 25, 2014
Important factors for achieving survival of five years or more in non-small cell lung cancer patients with distant metastasisTomonori Hirashima, Hidekazu Suzuki, Norio Okamoto, et al.
Investigational New Drugs|June 17, 2020
Safety and efficacy of afatinib for the treatment of non-small-cell lung cancer following osimertinib-induced interstitial lung disease: A retrospective studyShingo Nasu, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Anticancer Research|April 12, 2012
Long-term amrubicin chemotherapy for small-cell lung cancerMasayoshi Higashiguchi, Hidekazu Suzuki, Tomonori Hirashima, et al.
Investigational New Drugs|March 15, 2018
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancerMotohiro Tamiya, Hidekazu Suzuki, Takayuki Shiroyama, et al.
Respiratory Medicine Case Reports|March 1, 2018
Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinomaShingo Satoh, Takayuki Shiroyama, Motohiro Tamiya, et al.
Scientific Reports|May 6, 2021
The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLCMotohiro Tamiya, Akihiro Tamiya, Norio Okamoto, et al.
Pageof 14